Changes of specific antibody and neutralizing antibody after voluntary blood donors received COVID-19 vaccine
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 1
Abstract
Objective To analyze the changes in antibody titer of voluntary blood donors after receiving the COVID-19 vaccine, so as to provide reference for blood donation strategy, follow-up vaccine development and COVID-19 prevention and treatment for healthy people. Methods 1) The serum from voluntary blood donors 2, 4, 8, 12, 16 and 20 weeks after inoculation with two-shot vaccines (inactivated vaccine or recombinant protein vaccine) was collected, and SARS-CoV-2 total antibody (IgG+ IgM+ IgA) detection (colloidal gold method) and neutralizing antibody detection (UPT immunoluminescence method) were conducted. 2) The obtained data were grouped according to collection time, age and gender, and differences between groups were analyzed by t test and ANOVA using SPSS 2.0 statistical software to clarify the trend of total antibodies and neutralizing antibodies. Results Neutralizing antibodies and total antibodies (IgG+ IgM+ IgA) from voluntary blood donors vaccinated inactivated vaccine or recombinant vaccine had the same trend of change, both reached their peak at the 2nd and 4th week, respectively, after inoculation, and then decreased gradually. The antibody produced by the recombinant protein vaccine had a higher titer than that from inactivated vaccine, and had slower decline and more lasting protection. The neutralizing antibody and total antibody (IgG+ IgM+ IgA) from different genders and ages were not statistically different. Conclusion Neutralizing antibodies reached its peak in the second week after vaccination, and total antibody titer reached its peak in the fourth week; both were independent of age and gender. After receiving the vaccine, voluntary blood donors should follow the latest instructions on blood donation intervals issued by the government.
Authors and Affiliations
Songyan WU, Yunfeng PU, Suochun CAO, Siyun XU
Keywords
Related Articles
- EP ID EP738457
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.01.006
- Views 50
- Downloads 0
The gene polymorphism and phenotype of RhD variants among blood donors in Chongqing
Objective To conduct Rh blood group serological testing and third-generation sequencing(TGS) on 22 RhD variant voluntary blood donors in Chongqing and explore the phenotypic distribution and genotyping of RhD variants in...
Detection and analysis of antibodies against SARS-CoV-2 in blood donors at different periods in Guangzhou
Objective To detect the anti-SARS-CoV-2 antibody levels in blood donors in Guangzhou, so as to provide laboratory data support for the collection and clinical use of convalescent plasma. Methods Anti-SARS-CoV-2 antibodie...
Development and application of blood donor role identity scale (BDRIS)
Objective To further determine the relationship between blood donor role cognition and blood donation behavior, then prepare of blood donor role identity scale(BDRIS). Methods The preparation of the scale was divided int...
Expert consensus on screening for unexpected red blood cell antibodies
Unexpected red blood cell antibodies refer to antibodies except for anti-A and anti-B in normal ABO blood group, and are widely present in patients with pregnancy, transfusion, transplantation, injection of immunogenic s...
Perioperative blood management of a patient with coagulation factor Ⅴ deficiency and literature review
Objective To explore the perioperative blood management in patients with pancreatic pseudocyst combiend with coagulation factor Ⅴ(FⅤ) deficiency. Methods Preoperative: In order to determine the effect of cryoprecipitated...